HITI
High Tide Inc.
HITI's outlook is improving, though it still trails on the overall score.
LLY
Eli Lilly and Company
LLY has the edge over HITI overall, supported by stronger fundamentals and stronger modeled upside.
HITI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Under pressure | |
| Weak |
HITI's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
HITI PE Valuation
HITI has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
HITI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HITI, with profitability improving.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
HITI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.27 | -$0.22 |
| Q2 2026 | -$0.35 | -$0.30 |
| Q1 2026 | -$0.38 | -$0.36 |
| Q4 2025 | -$0.41 | -$0.41 |
| Q4 2024 | -$0.00 | +$0.37 |
| Q4 2023 | -$0.37 | +$0.38 |
| Q3 2023 | -$0.60 | -$0.31 |
| Q2 2023 | -$0.60 | -$0.32 |
HITI is still losing money, but far less than before: $0.27 per share over the past year, against $1.38 at its worst in early 2020.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over HITI on earnings quality, reporting a profit while its opponent remains loss making.
HITI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $141.3M | +34% |
| Q2 2026 | $126.1M | +30% |
| Q1 2026 | $125.6M | +25% |
| Q4 2025 | $115.3M | +19% |
| Q3 2025 | $105.2M | +14% |
| Q2 2025 | $96.9M | +11% |
| Q1 2025 | $100.2M | +11% |
| Q4 2024 | $97.2M | +8.8% |
HITI's revenue has grown year over year every quarter since early 2021: $141M last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.3% | +1.8 points |
| Q2 2026 | 4.5% | +3.8 points |
| Q1 2026 | 2.3% | +2.3 points |
| Q4 2025 | -12% | -9.6 points |
| Q3 2025 | 2.5% | +0.2 points |
| Q2 2025 | 0.7% | -0.9 points |
| Q1 2025 | 0.1% | -2.1 points |
| Q4 2024 | -2% | N/A |
HITI's operating margin was 4.3% last quarter, up 1.8 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over HITI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over HITI on profitability, with a higher operating margin.
HITI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.5M | +10% |
| Q2 2026 | $1.6M | -59% |
| Q1 2026 | $2.2M | +$3.7M |
| Q4 2025 | $812.7K | -85% |
| Q3 2025 | $5.9M | +206% |
| Q2 2025 | $4M | -46% |
| Q1 2025 | -$1.4M | -143% |
| Q4 2024 | $5.4M | +2.4% |
HITI still generates free cash flow, though less than at its 2024 peak: $11M over the past year.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over HITI on cash flow, with more consistent year-over-year improvement.
HITI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.6% | +6.7M shares |
| 1 year | +6.8% | +6M shares |
| 3 years | +26% | +19.6M shares |
| 5 years | +96% | +46.2M shares |
| Available history | +672% | +82.3M shares |
HITI has 95M diluted shares, up 6.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
HITI hasn't bought back shares in the past year.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over HITI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
HITI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 17.4x | High |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 0.8x | Very low |
| Q3 2022 | 5.6x | High |
| Q2 2022 | 5.1x | High |
| Q1 2022 | 7.5x | High |
HITI's net debt is about 17 years of its operating earnings (EBITDA), up from less than a year a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over HITI on leverage, with a lower net debt burden relative to earnings.
HITI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.0 | Neutral |
| Stochastic | 59.7 | Neutral |
HITI's weekly RSI is 50 (neutral) and its Stochastic is 60 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
HITI PE vs Healthcare Sector
HITI has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
HITI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.61 | 4.2% below |
| 20 week MA | $2.46 | 1.6% above |
| 50 week MA | $2.46 | 1.6% above |
| 100 week MA | $2.59 | 3.5% below |
| 200 week MA | $2.20 | 14% above |
HITI's trend is mixed: it's above three of its five weekly moving averages, and 14% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over HITI on trend strength, trading above more of its moving averages.
HITI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $3.15 | $4.70 | +49% |
| 2022 | $4.70 | $1.43 | -70% |
| 2023 | $1.43 | $1.63 | +14% |
| 2024 | $1.63 | $3.05 | +87% |
| 2025 | $3.05 | $2.78 | -8.9% |
| 2026 YTD | $2.78 | $2.50 | -10% |
HITI has finished higher in three of the last five years. It's down 10% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over HITI on returns for 2026, with the stronger performance.